Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Freeze Off is an over-the-counter cryogenic treatment used for the removal of common and plantar warts. It typically consists of a pressurized aerosol canister containing a mixture of dimethyl ether and propane (DMEP). When applied via a specialized applicator, the refrigerant mixture rapidly evaporates, reaching temperatures as low as -55°C to -70°C. This extreme cold induces localized cryonecrosis, freezing the wart tissue and the underlying Human Papillomavirus (HPV) infected cells. The process causes the formation of an ice ball within the skin, leading to cellular dehydration, protein denaturation, and vascular stasis. Following treatment, a blister usually forms beneath the wart, and the dead tissue sloughs off within 10 to 14 days, allowing for the regeneration of healthy skin tissue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Freeze Off.